Concepedia

Kyle L. Flannigan

KL

24

Publications

1.5K

Citations

21

H-Index

1999

Active since

Affiliations

University of Calgary(Current)

McMaster University

Albert Einstein College of Medicine

Population Health Research Institute

Alberta Children's Hospital

Kyle L. Flannigan is an author at University of Calgary specializing in medicine, pharmacology, and inflammation.

ORCID

Top concepts

Publications per year

1999–2022

24

Publications

24

Hydrogen Sulfide Protects from Colitis and Restores Intestinal Microbiota Biofilm and Mucus Production

Jean‐Paul Motta, Kyle L. Flannigan, Terence A. Agbor et al. · Inflammatory Bowel Diseases · 2015 · 209 citations · Full text

IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria

Kyle L. Flannigan, Vu L. Ngo, Duke Geem et al. · Mucosal Immunology · 2016 · 136 citations · Full text

, , +6

Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage

Óscar Medina‐Contreras, Akihito Harusato, Hikaru Nishio et al. · The Journal of Immunology · 2015 · 126 citations · Full text

, , +15

Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity

Michael R. Taylor, Kyle L. Flannigan, Hannah Rahim et al. · Science Advances · 2019 · 117 citations · Full text

Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis

Kyle L. Flannigan, Terence A. Agbor, Rory W. Blackler et al. · Proceedings of the National Academy of Sciences · 2014 · 97 citations · Full text

Rows per page

1–5 of 24